RACS has joined with specialty societies in writing to the Australian Competition Tribunal. The letter is in regards to the application by Honeysuckle Healthcare Pty Ltd (HH) and other applicants (nib) ‘buying group’ and the up-and-coming Australian Medical Association hearing in the Tribunal.
RACS has previously opposed an application by Honeysuckle Healthcare Pty Ltd and other applicants for authorisation to form and operate a buying group.
Update August 2022: A legally binding agreement has been reached with HH which reinforces strong protections for doctors and patients for specialist services funded by private health insurers who choose to participate in the HH buying group. THe AMA have provided a summary of the determination on their website.